Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor

Journal of Medicinal Chemistry

Volumn 41, Issue 27, 1998, Pages 5457-5465

  Palmer, Brian D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1 PHENYLBENZIMIDAZOLE; IMIDAZOLE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CONCENTRATION RESPONSE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; BENZIMIDAZOLES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RATS; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032585549     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9804681     Document Type: Article

References (36)

1. Claesson-Welsh, L. PGDF receptors: structure and mechanism of action. Cytokines 1993, 5, 31-43.
2. Meyer-Ingold, W.; Eichner, W. Platelet-derived growth factor. Cell Biol. Int. 1995,19, 389-398.
3. Iwama, A.; Sawamura, M.; Nara, Y.; Yamori, Y. Phosphatidylinositol 3-kinase (PI3K) appears to have a crucial role in cellular proliferation induced by platelet-derived growth factor (PDGF). Clin. Exp. Pharm. Physiol. 1995,22 (Suppl. 1), S318-S320.
4. Okamoto, S.; Indenk, M.; Setsuda, M.; Konishi, T.; Nakano, T. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am. Heart J. 1992, 723, 1439-1444.
5. Sawutz, D. G.; Bode, D. C.; Briggs, M.; Reid, J. R.; Canniff, P.; Caldwell, L.; Faltynek, C. R.; Miller, D.; Dünn, J. A.; de Garavilla, L.; Guiles, J. W.; Weigelt, C.; Michne, W.; Treasurywala, A. M.; Silver, P. J. In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors. Biochem. Pharmacol. 1996, 51, 1631-1638.
6. Plate, K. H.; Breier, G.; Risau, W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathology 1994, 4, 207-218.
7. Westermark, B.; Heldin, C. H. Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth. Acta Oncol. 1993, 32, 101-105.
8. Smits, A.; Funa, K.; Vassbotn, F. S.; Beausang-Linder, M.; Ekenstam, F.; Heldin, C. H.; Westermark, B.; Nister, M. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. Am. J. Path. 1992, 140, 639-648.
9. Fleming, T. P.; Matsui, T.; Heidaran, M. A.; Molloy, C. J.; Artrip, J.; Aaronson, S. A. Demonstration of an activated plateletderived growth factor automne pathway and its role in human tumor cell proliferation in vitro. Oncogene 1992, 7,1355-1339.
10. Fry, D. W. Recent advances in tyrosine kinase inhibitors. Ann. Rep. Med. Chem. 1996, 31, 151-160.
11. Maguire, M. P.; Sheets, K. R.; McVety, K; Spada, A. P.; Zilberstein, A. A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. J. Med. Chem. 1994, 37, 2129-2137.
12. Dolle, R. E.; Dünn, J. A.; Bobko, M.; Singh, B.; Küster, J. E.; Baizman, E.; Harris, A. L.; Sawutz, D. G.; Miller, D.; Wang, S.; Faltynek, C. R.; Xie, W.; Sarup, J.; Bode, C. E.; Pagani, E. D.; Silver, P. J. 5,7-Dimethoxy-3-(4-pyridinyl)quinoline is a potent and selective inhibitor of human vascular β-type platelet-derived growth factor receptor tyrosine kinase. J. Med. Chem. 1994,37, 2627-2629.
13. Kovalenko, M.; Gazit, A.; Bohmer, A.; Rorsman, C.; Rönnstrand, L.; Heldin, C. H.; Waltenberger, J.; Bohmer, F. D.; Levitzki, A. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res. 1994, 54, 6106-6114.
14. Shawver, L.; K; Schwartz, D. P.; Mann, E.; Chen, H.; Tsai, J. M.; Chu, L.; Taylorson, L.; Longhi, M.; Meredith, S.; Germain L.; Jacobs, J. S.; Tang, C.; Ullrich, A.; Berens, M. E. Hersh, E.; McMahon, G.; Hirth, K. P. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]-5-methylisoxazole-4-carboxamide. Clin. Concernes. 1997,3, 1167-1177.
15. Malkin, M. G.; Mason, W. P.; Liebermann, F. S.; Hannah, A. L. Phase I study of SU101, a novel signal transduction inhibitor, in recurrent malignant gliomas. Proc. Am. Soc. Clin. Oncol. 1997, 16, 385a (abstr. 1371).
16. Katritzky, A. R.; Lang, H.; Lan, X. A new route to N-substituted heterocycles. Tetrahedron 1993, 49, 2829-2838.
17. Dornow, A.; Thiedel, H. Reductions of α-ketonitriles and isonitrosoketones with lithium aluminium hydride (Reductions with LiAlH4. Part 4). Chem. Ber. 1955, 88, 1267-1274.
18. Hideg, K; Hankovszky, H. O. Benzazepines. III. Preparation of lH-2,3-dihydro-6,7-benzo[l,5]-diazepines. Acta Chim. (Budapest) 1968, 57, 213-217.
19. Hallberg, A.; Deardorff, D.; Martin, A. A modified Bischler synthesis of some tetracyclic indole derivatives. Heterocycles 1982,19, 75-82.
20. Borsche, W.; Diacont, K. On 1-arylindazole. Liebigs Ann. Chim. 1934, 510, 287-297.
21. Brown, R. A.; Fernando, S. I. S.; Roberts, R. M. G. Decomplexation of (η-arene)(η-cyclopentadienyDiron (II) hexafluorophosphates: a convenient one-pot arylation procedure. J. Chem. Soc., Perkin Trans, l 1994, 197-202.
22. Fischer, O.; Rigaud, M. On benzimidazole. Chem. Ber. 1901,34, 4202-4209.
23. Clémence, F.; Le Martret O. 1-Phenylbenzimidazoles. German Patent no. 1914005; Chem. Abstr. 1970, 73, 66577g.
24. Mackay, M. F.; Trantino, G. J.; Wilshire, J. F.K. The reaction of some JV-(nitrophenyl)azoles with alkali: preparation of the corresponding azoxybenzenes. X-ray structure of 2,2′-bis(l″,2″,4″-triazol-l″-yl)azoxybenzene. Aust. J. Chem. 1993, 46, 417-425.
25. Belton, J. G.; Mclnerney, M. Antitubercular substances. XXI. Synthesis of 2-nitrodiphenylamines. Proc. R. Irish Acad. 1970, 69B, 20-29.
26. Montanari F.; Passerini R. Benzimidazoles. Boll. Sci. Facolta Chim. Ind. Bologna, 1953, 11, 42-45; Chem. Abstr. 1954, 48, 6436h.
27. Panek, R. L.; Lu, G. H.; Klutchko, S. R.; Batley, B. L.; Dahring, T. K; Hamby, J. M.; Hallak, H.; Doherty, A. M.; Keiser, J. A. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 1997,283, 1433-1444.
28. Batley, B. L.; Doherty, A. M.; Hamby, J. M.; Lu, G. H.; Keller, P.; Dahring, T. K.; Hwang, O.; Crickard, K; Panek, R. L. Inhibition of FGF-1 receptor tyrosine kinase activity by PD 161570, a new protein-tyrosine kinase inhibitor. Life Sci. 1997, 62, 143-150.
29. Smith, P. A. S.; Brown, B. B.; Putney, R. K.; Reinisch, R. F. The synthesis of heterocyclic compounds from aryl azides. III. Some six-membered rings and some azidobiaryls. J. Am. Chem. Soc. 1953, 75, 6335-6337.
30. Clark, R. L.; Pessolano, A. A. Synthesis of some substituted benzimidazoles. J. Am. Chem. Soc. 1958, 80, 1657-1662.
31. Joseph, L. Substituted 2-aminobenzimidazoles. J. Med. Chem. 1963, 6, 601-613.
32. Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Lipton, M.; Caulfield, C.; Chang, G.; Hendrickson, T.; Still, W. C. MacroModel-an integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J. Comput. Chem. 1990,11, 440-467.
33. Tsizin, T. S.; Chernyak, S. A. Study of heterocyclic quinones. XXXIII. Oxidative animation of 5(6)-hydroxybenzimidazoles. Khim. Geterotsikl. Soedin. 1978, 12, 1680-1683; Chem. Abstr. 1979, 90, 137728.
34. Reissert A.; Goll, G. Preparation of quinoxalines and benzimidazoles from 2-amino-4-nitrodiphenylamine. Chem. Ber. 1905, 38, 90-104.
35. Panek, R. L.; Lu, G. H.; Klutchko, S. R.; Batley, B. L.; Dahring, T. K.; Hamby, J. M.; Hallak, H.; Doherty, A. M.; Keiser, J. A. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 1997, 283, 1433-1444.
36. Rosevear, J.; Wilshire, J. F. K Cyclization reactions in azole chemistry: the reactions of some azoles with o-fluoroacetophenone, o-fluorobenzaldehyde and o-fluorobezophenone. Aust. J. Chem. 1991, 44, 1097-1114.